{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:25:19Z","timestamp":1790378719707,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017MPCWPY"],"award-info":[{"award-number":["2017MPCWPY"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["848223"],"award-info":[{"award-number":["848223"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF 2013-02359333"],"award-info":[{"award-number":["RF 2013-02359333"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cld.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T16:28:22Z","timestamp":1688488102000},"page":"819-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["What Is the Current Status of Hepatitis B Virus Viro-Immunology?"],"prefix":"10.1016","volume":"27","author":[{"given":"Carolina","family":"Boni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Montali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Tiezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Doselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Reverberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Ceccatelli Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Montali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Schivazappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Laccabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Missale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fisicaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2023.05.001_bib1","doi-asserted-by":"crossref","unstructured":"GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol, 2022; 7: 796\u2013829.","DOI":"10.1016\/S2468-1253(22)00124-8"},{"key":"10.1016\/j.cld.2023.05.001_bib2","article-title":"Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis","year":"2016","journal-title":"World Health Organization"},{"issue":"2","key":"10.1016\/j.cld.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jhep.2016.01.028","article-title":"The role of innate immunity in the immunopathology and treatment of HBV infection","volume":"64","author":"Maini","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T\u00a0cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.cld.2023.05.001_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205080","article-title":"The good and the bad of natural killer cells in virus control: perspective for anti-HBV therapy","volume":"20","author":"Fisicaro","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus\u2013specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"s1","key":"10.1016\/j.cld.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/liv.12749","article-title":"HBV and the immune response","volume":"35","author":"Ferrari","year":"2015","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI118902","article-title":"Long-lasting memory T\u00a0cell responses following self-limited acute hepatitis B","volume":"98","author":"Penna","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2023.05.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2023.05.001_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327202","article-title":"Phenotypic CD8 T\u00a0cell profiling in chronic hepatitis B to predict HBV-specific CD8 T\u00a0cell susceptibility to functional restoration in\u00a0vitro","author":"Rossi","year":"2023","journal-title":"Gut"},{"issue":"32","key":"10.1016\/j.cld.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"eaau6905","DOI":"10.1126\/sciimmunol.aau6905","article-title":"Multifactorial heterogeneity of virus-specific T\u00a0cells and association with the progression of human chronic hepatitis B infection","volume":"4","author":"Cheng","year":"2019","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T\u00a0cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","article-title":"Phenotype and function of HBV-specific T\u00a0cells is determined by the targeted epitope in addition to the stage of infection","volume":"68","author":"Hoogeveen","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cld.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/gutjnl-2020-322404","article-title":"TOX defines the degree of CD8+ T\u00a0cell dysfunction in distinct phases of chronic HBV infection","volume":"70","author":"Heim","year":"2021","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2012.06.009","article-title":"Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B","volume":"143","author":"Kennedy","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2020.04.019","article-title":"Effects of hepatitis B surface antigen on virus-specific and global T\u00a0cells in patients with chronic hepatitis B virus infection","volume":"159","author":"Le Bert","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T\u00a0cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2022.03.028","article-title":"The challenges of adopting immunological biomarkers in the management of chronic HBV infection","volume":"77","author":"Bertoletti","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12072-017-9829-7","article-title":"Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread","volume":"11","author":"Karayiannis","year":"2017","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.cld.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/liv.13346","article-title":"Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients","volume":"70","author":"Testoni","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"3\u20134","key":"10.1016\/j.cld.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1053\/j.gastro.2009.08.061","article-title":"Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa","volume":"137","author":"Buster","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/liv.13635","article-title":"Treatment of hepatitis B: is there still a role for interferon?","volume":"38","author":"Vigan\u00f2","year":"2018","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jhep.2022.01.007","article-title":"Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels","volume":"76","author":"Sonneveld","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","article-title":"Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma","volume":"53","author":"Chan","year":"2004","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.05.001_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-022-00724-5","article-title":"The scientific basis of combination therapy for chronic hepatitis B functional cure","author":"Lim","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2023.05.001_bib35","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1136\/gutjnl-2021-326258","article-title":"HBV antigens quantity: duration and effect on functional cure","volume":"71","author":"Bertoletti","year":"2022","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/biomedicines10061224","article-title":"Antigen load and T\u00a0cell function: a challenging interaction in HBV infection","volume":"10","author":"Montali","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/imr.12953","article-title":"Human antiviral B cell responses: emerging lessons from hepatitis B and COVID-19","volume":"299","author":"Burton","year":"2021","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib38","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/hep4.1420","article-title":"Fine-tuning TLR-7-based therapy for functional HBV cure","volume":"3","author":"Bertoletti","year":"2019","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T\u00a0cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3390\/cells10102563","article-title":"Unraveling the multifaceted nature of CD8 T\u00a0cell exhaustion provides the molecular basis for therapeutic T\u00a0cell reconstitution in chronic hepatitis B and C","volume":"10","author":"Barili","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cld.2023.05.001_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib42","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jhep.2015.05.033","article-title":"Immune outcomes in the liver: is CD8 T\u00a0cell fate determined by the environment?","volume":"63","author":"Wong","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"25","key":"10.1016\/j.cld.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"E2540","DOI":"10.1073\/pnas.1406674111","article-title":"Antigen expression level threshold tunes the fate of CD8 T\u00a0cells during primary hepatic immune responses","volume":"111","author":"Tay","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"7","key":"10.1016\/j.cld.2023.05.001_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2015.12.060","article-title":"Protein-prime\/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice","volume":"34","author":"Backes","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib45","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2020.01.032","article-title":"Knockdown of virus antigen expression Increases therapeutic vaccine efficacy in high-titer hepatitis B virus carrier mice","volume":"158","author":"Michler","year":"2020","journal-title":"Gastroenterology"},{"issue":"7777","key":"10.1016\/j.cld.2023.05.001_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","article-title":"Dynamics and genomic landscape of CD8+ T\u00a0cells undergoing hepatic priming","volume":"574","author":"B\u00e9n\u00e9chet","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.cld.2023.05.001_bib48","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200298","article-title":"Serum HBsAg clearance has minimal impact on CD8+ T\u00a0cell responses in mouse models of HBV infection","volume":"217","author":"Fumagalli","year":"2020","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T\u00a0cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib51","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T\u00a0cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"18","key":"10.1016\/j.cld.2023.05.001_bib52","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6332","key":"10.1016\/j.cld.2023.05.001_bib53","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T\u00a0cell costimulatory receptor CD28 is a primary target for PD-1\u2013mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cld.2023.05.001_bib54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A\u00a0transcriptionally and functionally distinct PD-1(+) CD8(+) T\u00a0cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s40425-019-0628-7","article-title":"PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes","volume":"7","author":"Ogando","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T\u00a0cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib57","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib58","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"issue":"33","key":"10.1016\/j.cld.2023.05.001_bib59","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.cld.2023.05.001_bib60","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-Specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib61","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1053\/j.gastro.2012.08.041","article-title":"Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T\u00a0cells against HBV, but not HCV","volume":"143","author":"Fisicaro","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib62","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T\u00a0cell function by PD-1 blockade in inactive carrier patients is linked to T\u00a0cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.05.001_bib63","doi-asserted-by":"crossref","first-page":"e105703","DOI":"10.1371\/journal.pone.0105703","article-title":"Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules","volume":"9","author":"Raziorrouh","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12865-019-0309-9","article-title":"CD4+ T\u00a0cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T\u00a0cell function in chronic hepatitis B","volume":"20","author":"Dong","year":"2019","journal-title":"BMC Immunol"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib65","doi-asserted-by":"crossref","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the tim-3\/galectin-9 pathway of T\u00a0cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib66","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T\u00a0cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib67","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.05.001_bib68","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can Be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B","volume":"72","author":"Le Bert","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.05.001_bib70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T\u00a0cells in chronic hepatitis B","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib71","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct metabolic requirements of exhausted and functional virus-specific CD8 T\u00a0cells in the same host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.cld.2023.05.001_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.02.035","article-title":"Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T\u00a0cell reconstitution in chronic hepatitis B","author":"Montali","year":"2023","journal-title":"J.Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib73","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2020.10.034","article-title":"Functional reconstitution of HBV-specific CD8 T\u00a0cells by in\u00a0vitro polyphenol treatment in chronic hepatitis B","volume":"74","author":"Acerbi","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.05.001_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib75","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","article-title":"Regulation of intracellular levels of NAD: a novel role for CD38","volume":"345","author":"Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus","volume":"22","author":"Cant\u00f3","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.cld.2023.05.001_bib77","doi-asserted-by":"crossref","first-page":"119803","DOI":"10.1016\/j.lfs.2021.119803","article-title":"A\u00a0comprehensive review of Sirtuins: with a major focus on redox homeostasis and metabolism","volume":"282","author":"Shahgaldi","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.cld.2023.05.001_bib78","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib79","first-page":"2595","article-title":"Role and mechanism of programmed death-ligand1 in hypoxia-induced liver cancer immune escape (Review)","volume":"19","author":"Wen","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.cld.2023.05.001_bib80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fimmu.2018.00635","article-title":"The contribution of non-professional antigen-presenting cells to immunity and tolerance in the liver","volume":"9","author":"Mehrfeld","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.cld.2023.05.001_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib82","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T\u00a0cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MOT.0b013e3282f3dee1","article-title":"The role of tryptophan catabolism in acquisition and effector function of memory T\u00a0cells","volume":"13","author":"Dai","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cld.2023.05.001_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int J Tryptophan Res"},{"issue":"6349","key":"10.1016\/j.cld.2023.05.001_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Scienc"},{"issue":"11","key":"10.1016\/j.cld.2023.05.001_bib86","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T\u00a0cell receptor \u03b6-chain and induce a regulatory phenotype in naive T\u00a0cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.cld.2023.05.001_bib87","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T\u00a0cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ"},{"issue":"11","key":"10.1016\/j.cld.2023.05.001_bib88","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/eji.200636704","article-title":"Ido expands human CD4+CD25high regulatory T\u00a0cells by promoting maturation of LPS-treated dendritic cells","volume":"37","author":"Hill","year":"2007","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib89","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.cld.2023.05.001_bib90","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2012.03.041","article-title":"Increased levels of arginase in patients with acute hepatitis B suppress antiviral T\u00a0cells","volume":"143","author":"Sandalova","year":"2012","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2023.05.001_bib92","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.20072076","article-title":"Functional skewing of the global CD8 T\u00a0cell population in chronic hepatitis B virus infection","volume":"205","author":"Das","year":"2008","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib93","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","article-title":"Immune tolerance in liver disease","volume":"60","author":"Crispe","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.05.001_bib94","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","article-title":"Prostaglandins as modulators of immunity","volume":"23","author":"Harris","year":"2002","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.cld.2023.05.001_bib95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","article-title":"Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation","volume":"103","author":"Hata","year":"2004","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib96","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/icb.2011.75","article-title":"Prostaglandin E 2 and T\u00a0cells: friends or foes?","volume":"90","author":"Sreeramkumar","year":"2012","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib97","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.3831","article-title":"Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection","volume":"21","author":"Chen","year":"2015","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib98","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cld.2023.05.001_bib99","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.molimm.2018.08.009","article-title":"Prostaglandin E2 facilitates Hepatitis B virus replication by impairing CTL function","volume":"103","author":"Li","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cld.2023.05.001_bib100","doi-asserted-by":"crossref","first-page":"104025","DOI":"10.1016\/j.cellimm.2019.104025","article-title":"PGE2 ameliorated viral myocarditis development and promoted IL-10-producing regulatory B cell expansion via MAPKs\/AKT-AP1 axis or AhR signaling","volume":"347","author":"Chen","year":"2020","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib101","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E2\u2013dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2023.05.001_bib102","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2018.01859","article-title":"Prostaglandin E2 secreted by thyroid cancer cells contributes to immune escape through the suppression of natural killer (NK) cell cytotoxicity and NK cell differentiation","volume":"9","author":"Park","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","article-title":"Regulation of immune responses by prostaglandin E2","volume":"188","author":"Kalinski","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib104","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib105","doi-asserted-by":"crossref","first-page":"158674","DOI":"10.1016\/j.bbalip.2020.158674","article-title":"Retinoids in health and disease: a role for hepatic stellate cells in affecting retinoid levels","volume":"1865","author":"Haaker","year":"2020","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"issue":"5","key":"10.1016\/j.cld.2023.05.001_bib106","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4049\/jimmunol.1201937","article-title":"Hepatic stellate cells preferentially induce Foxp3+ regulatory T\u00a0cells by production of retinoic acid","volume":"190","author":"Dunham","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib107","first-page":"G809","article-title":"Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1","volume":"293","author":"Radaeva","year":"2007","journal-title":"Am J Physiol Liver Physiol"},{"issue":"1","key":"10.1016\/j.cld.2023.05.001_bib108","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T\u00a0cells susceptible to NK cell\u2013mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.cld.2023.05.001_bib109","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1073\/pnas.1118834109","article-title":"Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity","volume":"109","author":"Lang","year":"2012","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2023.05.001_bib110","first-page":"408","article-title":"NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T\u00a0cell responses","volume":"3","author":"Zingoni","year":"2012","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.cld.2023.05.001_bib111","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","article-title":"Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis","volume":"110","author":"Cerboni","year":"2007","journal-title":"Blood"},{"issue":"6371","key":"10.1016\/j.cld.2023.05.001_bib112","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aam8825","article-title":"Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells","volume":"359","author":"Ramsuran","year":"2018","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cld.2023.05.001_bib113","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib114","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","article-title":"Type I interferons protect T\u00a0cells against NK cell attack mediated by the activating receptor NCR1","volume":"40","author":"Crouse","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cld.2023.05.001_bib115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/hep.28155","article-title":"Natural killer cell phenotype modulation and natural killer\/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B","volume":"62","author":"Boni","year":"2015","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.05.001_bib116","doi-asserted-by":"crossref","first-page":"e1001227","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.cld.2023.05.001_bib117","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4049\/jimmunol.1601313","article-title":"T\u00a0cells infiltrating diseased liver express ligands for the NKG2D stress surveillance system","volume":"198","author":"Huang","year":"2017","journal-title":"J\u00a0Immunol"},{"issue":"640","key":"10.1016\/j.cld.2023.05.001_bib118","doi-asserted-by":"crossref","first-page":"eabi4670","DOI":"10.1126\/scitranslmed.abi4670","article-title":"NK cells limit therapeutic vaccine-induced CD8(+)T cell immunity in a PD-L1-dependent manner","volume":"14","author":"Diniz","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cld.2023.05.001_bib119","doi-asserted-by":"crossref","first-page":"884290","DOI":"10.3389\/fimmu.2022.884290","article-title":"Natural killer cells induce CD8(+) T\u00a0cell dysfunction via galectin-9\/TIM-3 in chronic hepatitis B virus infection","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:01:13Z","timestamp":1761069673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1089326123000612"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.05.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What Is the Current Status of Hepatitis B Virus Viro-Immunology?","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}